MedPath

CLINDAMYCIN PHOSPHATE INJECTION USP LIQ

CLINDAMYCIN PHOSPHATE INJECTION USP LIQ

Discontinued
DIN Number

02051826

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

lyphomed, division of fujisawa canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02051826
AIG Number0142244001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FF01 CLINDAMYCIN
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification08:12.28.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLINDAMYCIN PHOSPHATEActive
Strength: 150 MG / ML
Monograph: CLINDAMYCIN PHOSPHATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.